Sign up to save your podcasts
Or
Share Making a difference: Molecules, mechanisms and more
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Making a difference: Molecules, mechanisms and more
Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer
View all episodes
By Gynecologic Oncology
5
1919 ratings
Editor’s Choice: A phase II, randomized, double-blind study of the use of rucaparib vs. placebo maintenance therapy in metastatic and recurrent endometrial cancer
More shows like Listen to Gynecologic Oncology
View all
Gynecologic Oncology Update
12 Listeners
The Daily
113,035 Listeners
Ready, Set, GYO!
30 Listeners